HTB
-
Featured
HTB: no. 4 – plus HIV and COVID-19 (1 April 2021)
1 April 2021. Related: Editorial, Early access.
-
Featured
CROI 2021: First results using capsid inhibitor lenacapavir against MDR HIV: potential for six-monthly ART and PrEP
1 April 2021. Related: Conference reports, Antiretrovirals, CROI 2021 (virtual).
-
Featured
HTB: no. 3 – plus HIV and COVID-19 (12 March 2021)
12 March 2021. Related: Editorial, Special reports.
-
Featured
HTB: no. 2 – plus HIV and COVID-19 (24 February 2021)
24 February 2021. Related: Editorial.
-
Featured
HTB: no. 1 – plus HIV and COVID-19 (22 January 2021)
22 January 2021. Related: Editorial.
-
Featured
HTB: no. 13/14 – HIV and COVID-19: issue 10 (9 December 2020)
9 December 2020. Related: Editorial.
-
Featured
HTB: no. 12 – HIV and COVID-19: issue 9 (11 November 2020)
11 November 2020. Related: Editorial.
-
Featured
In Memory: Timothy Ray Brown, the Berlin patient, the first person to be cured of HIV
14 October 2020. Related: In Memory.
-
US post-authorisation safety data on Pfizer and Moderna vaccines
15 April 2021. Related: Early access, COVID-19: vaccine research, COVID-19.
-
US CDC includes HIV as medical criteria for priority to COVID-19 vaccines
15 April 2021. Related: Early access, COVID-19: guidelines, COVID-19.
-
NICE guidelines on management of chronic pain: exercise but not opiods
9 April 2021. Related: Early access, Guidelines, Side effects, OIs, coinfections and complications.
-
Bar opening in the US: 100 guests linked to at least 46 cases of COVID-19
9 April 2021. Related: Early access, COVID-19: transmission & prevention, COVID-19.
-
i-Base appeal: please support i-Base with £5 or £10 a month
1 April 2021. Related: Editorial.
-
28th Conference on Retroviruses on Opportunistic Infections (CROI 2021)
1 April 2021. Related: Conference reports.
-
CROI 2021: Pregnancy outcomes and weight gain with dolutegravir and TAF
1 April 2021. Related: Conference reports, Pregnancy, CROI 2021 (virtual).
-
CROI 2021: New compounds for prevention and treatment of COVID-19
1 April 2021. Related: Conference reports, COVID-19: investigational drugs, COVID-19, CROI 2021 (virtual).
-
Oral molnupiravir at higher dose reduces SARS-CoV-2 viral load at day five in small phase 2 study
1 April 2021. Related: Conference reports, COVID-19: investigational drugs, COVID-19, CROI 2021 (virtual).
-
Bamlanivimab prophylaxis reduces hospitalisation and mortality: results from phase 3 BLAZE-2 study
1 April 2021. Related: Conference reports, COVID-19: investigational drugs, COVID-19, CROI 2021 (virtual).
-
Dual Eli-Lilly mAb bamlanivimab and etesevimab reduces hospitalisation after single infusion: results from BLAZE-1 study
1 April 2021. Related: Conference reports, COVID-19: investigational drugs, COVID-19, CROI 2021 (virtual).
-
Dual Regeneron mAbs casirivimab with imdevimab reduce transmission: interim results from phase 3 study
1 April 2021. Related: Conference reports, COVID-19: investigational drugs, COVID-19, CROI 2021 (virtual).
-
CROI 2021: Presentations from the LEAP workshop 2021
1 April 2021. Related: Conference reports, Other news, CROI 2021 (virtual).
-
CROI 2021: Presentations on NATAP.org
1 April 2021. Related: Conference reports, Other news, CROI 2021 (virtual).
-
Gilead and Merck/MSD to collaborate on long-acting HIV combination of lenacapavir and islatravir
1 April 2021. Related: Antiretrovirals.
-
Calls to reverse proposed UK cuts to global health research
1 April 2021. Related: Other news.
-
BHIVA guidelines on COVID-19 vaccines and people living with HIV: DRAFT online for comment
1 April 2021. Related: Guidelines, COVID-19: guidelines, COVID-19.
-
BHIVA advice on access to COVID-19 vaccines and shielding in the UK
1 April 2021. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
-
US phase 3 results enable FDA review of the Oxford/AstraZeneca vaccine
1 April 2021. Related: COVID-19: vaccine research, COVID-19.
-
Future meetings and webinars 2021
1 April 2021. Related: Future meetings.
-
HTB: no.4 – plus HIV and COVID-19 (1 April 2021)
1 April 2021. Related: PDFs.
-
In Memory: Dr Charles Boucher, leading HIV doctor, researcher and educator
12 March 2021. Related: In Memory.
-
28th Conference on Retroviruses and Opportunistic Infections (CROI 2021)
12 March 2021. Related: Conference reports, Conference index, CROI 2021 (virtual).
-
CROI 2021: Urgency of global access to vaccines, the potential of mAbs and the lessons learned from HIV
12 March 2021. Related: Conference reports, COVID-19: treatment access, COVID-19: investigational drugs, COVID-19, CROI 2021 (virtual).
-
CROI 2021: Community challenge 6-month CROI pay wall – rather than usual open access…
12 March 2021. Related: Conference reports, Other news, CROI 2021 (virtual).
-
CROI 2021: Once-daily GSK254 maturation inhibitor as treatment for HIV multidrug resistance
12 March 2021. Related: Conference reports, Antiretrovirals, CROI 2021 (virtual).
-
CROI 2021: Dosing for once-weekly oral ART: islatravir plus MK-8507 studies due to start in 2021
12 March 2021. Related: Conference reports, Antiretrovirals, CROI 2021 (virtual).
-
CROI 2021: Islatravir dosing for once-monthly and annual PrEP: if effective this could end HIV transmission
12 March 2021. Related: Conference reports, HIV prevention and transmission, CROI 2021 (virtual).
-
CROI 2021: Dolutegravir with recycled tenofovir and lamivudine performs well second-line: primary results from the NADIA trial
12 March 2021. Related: Conference reports, Treatment strategies, CROI 2021 (virtual).
-
CROI 2021: HIV capsid uncoats in the CD4 nucleus rather than the cytoplasm – viral lifecycle updated…
12 March 2021. Related: Conference reports, Virology, CROI 2021 (virtual).
-
CROI 2021: Community HIV cure workshops online
12 March 2021. Related: Conference reports, Cure research, CROI 2021 (virtual).
-
Chronic kidney disease (CKD) in HIV positive people linked to time with low CD4 count: partly reversible after effective ART
12 March 2021. Related: Side effects, OIs, coinfections and complications.
-
Janssen/J&J vaccine against COVID-19 is approved in the EU
12 March 2021. Related: COVID-19: vaccine research, COVID-19.
-
Baricitinib improves recovery in sub-group of adults hospitalised COVID-19: results from ACTT-2 study
12 March 2021. Related: COVID-19: investigational drugs, COVID-19.
-
Ivermectin has no impact in treating mild COVID-19 in 400 adults in Columbia
12 March 2021. Related: COVID-19: investigational drugs, COVID-19.
-
No benefit from BRII and GSK monoclonal antibodies against COVID-19 in ACTIV-3 study
12 March 2021. Related: COVID-19: investigational drugs, COVID-19.
-
HTB: no.3 – plus HIV and COVID-19 (12 March 2021)
12 March 2021. Related: PDFs.
-
In memory: Elias Phiri, community HIV and TB advocate
24 February 2021. Related: In Memory.
-
In memory: Dr Joseph Sonnabend, pioneer HIV activist and researcher
24 February 2021. Related: In Memory.
-
Timothy Ray Brown: a virtual memorial
24 February 2021. Related: In Memory.
-
R4P virtual conference (2021)
24 February 2021. Related: Conference reports, HIV prevention and transmission, Conference index, R4P 2021 Virtual.
-
VRC01 antibody only prevents minority of HIV infections: AMP study results
24 February 2021. Related: Conference reports, HIV prevention and transmission, R4P 2021 Virtual.
-
Long-acting bNAb is safe and well tolerated and achieves target concentrations in newborns (VRC07-523LS)
24 February 2021. Related: Conference reports, Paediatric care, HIV prevention and transmission, R4P 2021 Virtual.
-
Promising data for multipurpose technologies to prevent HIV and pregnancy
24 February 2021. Related: Conference reports, Pregnancy, HIV prevention and transmission, R4P 2021 Virtual.
-
12th International Workshop on HIV paediatrics
24 February 2021. Related: Conference reports, Conference index, 12th Paediatric HIV 2020.
-
New LPV/r-based fixed dose HIV combination for young children: first results with Quadrimune 4-in-1
24 February 2021. Related: Conference reports, Paediatric care.